Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Citi
Express Scripts
Deloitte
Cerilliant
Dow
Farmers Insurance
Cantor Fitzgerald
US Army

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MUCINEX DM

« Back to Dashboard

Clinical Trials for Mucinex Dm

Trial ID Title Status Sponsor Phase Summary
NCT00441246 Phase 4 Study - Mucinex D as Adjunct Therapy Completed Adams Respiratory Therapeutics Phase 4 The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respiratory infection.
NCT00902707 Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung Completed Reckitt Benckiser LLC Phase 1 The purpose of this research study is to test the ability of Mucinex, an oral, over-the-counter, FDA approved expectorant) to stimulate the clearance of inhaled particles from the subject's lungs (called "mucociliary clearance"). The study will also monitor the metabolism of the drug by the subject's body.
NCT00902707 Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung Completed University of North Carolina, Chapel Hill Phase 1 The purpose of this research study is to test the ability of Mucinex, an oral, over-the-counter, FDA approved expectorant) to stimulate the clearance of inhaled particles from the subject's lungs (called "mucociliary clearance"). The study will also monitor the metabolism of the drug by the subject's body.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Mucinex Dm

Condition Name

Condition Name for Mucinex Dm
Intervention Trials
Healthy Subjects 2
Acute Respiratory Infection 2
Bronchitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Mucinex Dm
Intervention Trials
Respiratory Tract Infections 4
Infection 3
Communicable Diseases 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Mucinex Dm

Trials by Country

Trials by Country for Mucinex Dm
Location Trials
United States 46
India 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Mucinex Dm
Location Trials
North Carolina 4
Massachusetts 3
Nebraska 3
Utah 2
New Jersey 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Mucinex Dm

Clinical Trial Phase

Clinical Trial Phase for Mucinex Dm
Clinical Trial Phase Trials
Phase 4 2
Phase 2/Phase 3 1
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Mucinex Dm
Clinical Trial Phase Trials
Completed 9
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Mucinex Dm

Sponsor Name

Sponsor Name for Mucinex Dm
Sponsor Trials
Reckitt Benckiser LLC 7
Adams Respiratory Therapeutics 1
Dr. Reddy's Laboratories Limited 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Mucinex Dm
Sponsor Trials
Industry 9
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Farmers Insurance
McKesson
Merck
Citi
Baxter
Cantor Fitzgerald
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.